The new directors bring extensive track records in scaling medtech companies, venture capital investment in life sciences, optimizing commercial organizations, and navigating complex financial and ...

The review by the Cochrane organisation -- which is considered the gold standard for analysing existing evidence -- looked at drugs that target a plaque called amyloids which builds up in the brains ...

PARIS – Drugs once hailed as a breakthrough in the fight against Alzheimer’s disease do not meaningfully help patients, a major review found on April 16, although some experts criticised the research.

Add Yahoo as a preferred source to see more of our stories on Google. Drugs once hailed as a breakthrough in the fight against Alzheimer's disease do not meaningfully help patients, a major review ...